OTCMKTS:HKMPF Hikma Pharmaceuticals - HKMPF Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. $20.64 0.00 (0.00%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$20.64▼$20.6450-Day Range$18.87▼$21.3652-Week Range$13.76▼$28.00VolumeN/AAverage Volume205 shsMarket Capitalization$4.55 billionP/E RatioN/ADividend Yield3.59%Price TargetN/A ProfileAnalyst RatingsChartCompetitorsHeadlinesShort Interest About Hikma Pharmaceuticals (OTCMKTS:HKMPF) StockHikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment sells branded generics and in-licensed patented products in the Middle East and North Africa. The Injectables segment includes generic injectable products distributed globally and primarily used in hospitals. The Generics segment focuses on oral and other non-injectable generic products, and is sold in the U.S. retail market. The Others segment comprises of Arab Medical Containers Ltd., International Pharmaceutical Research Center Ltd., and the chemicals division of Hikma Pharmaceuticals Ltd. (Jordan). The company was founded by Samih Taleb Darwazah in 1978 and is headquartered in London, the United Kingdom.Read More Receive HKMPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address HKMPF Stock News HeadlinesMarch 18, 2023 | marketwatch.comHikma Pharmaceuticals rises Thursday, still underperforms marketMarch 17, 2023 | americanbankingnews.comJefferies Financial Group Weighs in on Hikma Pharmaceuticals PLC's FY2025 Earnings (OTCMKTS:HKMPF)March 26, 2023 | Legacy Research (Affiliate) (Ad)"Prepare for Five Years of Famine"Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecastMarch 16, 2023 | americanbankingnews.comHikma Pharmaceuticals PLC (OTCMKTS:HKMPF) to Post FY2024 Earnings of $1.96 Per Share, Jefferies Financial Group ForecastsMarch 15, 2023 | marketwatch.comHikma Pharmaceuticals falls Monday, still outperforms marketMarch 9, 2023 | finance.yahoo.comHikma expands impact in Canada with launches of new sterile injectable medicinesFebruary 27, 2023 | finance.yahoo.comIs Hikma Pharmaceuticals PLC's (LON:HIK) Recent Stock Performance Influenced By Its Fundamentals In Any Way?February 23, 2023 | marketwatch.comHikma Pharmaceutical FY EPS 83.6cMarch 26, 2023 | Legacy Research (Affiliate) (Ad)"Prepare for Five Years of Famine"Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecastFebruary 22, 2023 | finance.yahoo.comHikma accuses Amarin of suppressing generic versions of heart pillDecember 28, 2022 | thestreet.comHikma Pharmaceuticals to Buy Generic Drug Maker Roxane for $2.65 BillionNovember 5, 2022 | benzinga.comHikma Pharmaceuticals Stock (OTC:HKMPF), Earnings Estimates, EPS, and RevenueSeptember 20, 2022 | finance.yahoo.comCould The Market Be Wrong About Hikma Pharmaceuticals PLC (LON:HIK) Given Its Attractive Financial Prospects?September 10, 2022 | seekingalpha.comHKMPF Hikma Pharmaceuticals PLCSeptember 9, 2022 | morningstar.comHikma Pharmaceuticals PLC HKMPF Stock ChartAugust 5, 2022 | seekingalpha.comHikma Pharmaceuticals PLC 2022 Q2 - Results - Earnings Call PresentationAugust 4, 2022 | proactiveinvestors.comHikma Pharma slides on lower generics guidanceAugust 4, 2022 | marketwatch.comHikma Pharmaceuticals Plc 1H Rev $1.21BJune 10, 2022 | finance.yahoo.comHikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 32% Above Their Intrinsic Value EstimateMay 24, 2022 | markets.businessinsider.comHikma Pharma CEO Siggi Olafsson Resigns - Quick FactsMay 5, 2022 | proactiveinvestors.com.auFTSE 100 soars after Wall St 'relief rally' and ahead of Bank of England decision but Hikma dropsApril 29, 2022 | finanznachrichten.deHikma Pharmaceuticals PLC: Hikma confirms that it has not signed a licensing agreement with Opiant PharmaceuticalsApril 25, 2022 | marketwatch.comHikma Pharmaceuticals Gets Low Support for Re-Election of Patrick Butler at AGMApril 20, 2022 | proactiveinvestors.com.auFTSE 100 flat but Wall Street makes a positive start despite Netflix flopApril 13, 2022 | finance.yahoo.comCross River Announces Completion of Inaugural Drill Campaign at the McVicar Gold Project, NW OntarioApril 13, 2022 | finance.yahoo.comIs Hikma Pharmaceuticals PLC's (LON:HIK) Stock's Recent Performance A Reflection Of Its Financial Health?March 29, 2022 | finance.yahoo.comHikma Ventures invests in Tact.ai, an AI-powered customer engagement platform for life sciences companiesSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive HKMPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address HKMPF Company Calendar Today3/26/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Private households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:HKMPF Previous SymbolOTC:HKMPF CUSIPN/A CIKN/A Webwww.hikma.com Phone442073992760Fax44-20-7399-2761Employees8,700Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$2.52 billion Price / Sales1.81 Cash Flow$2.41 per share Price / Cash Flow8.58 Book Value$10.18 per share Price / Book2.03Miscellaneous Outstanding Shares220,230,000Free FloatN/AMarket Cap$4.55 billion OptionableNot Optionable Beta0.53 Key ExecutivesSaid Samih Taleb DarwazahExecutive Chairman & Chief Executive OfficerKhalid Walid Hosni NabilsiChief Financial OfficerMazen Samih Taleb DarwazahExecutive Vice Chairman & President-MENA RegionMajda LabadiExecutive VP-Organizational DevelopmentRiad MishlawiPresident-Injectables DivisionKey CompetitorsAspen PharmacareOTCMKTS:APNHYAmplifonOTCMKTS:AMFPFUDG HealthcareOTCMKTS:UDHCFDiaSorinOTCMKTS:DSRLFGN Store Nord A/SOTCMKTS:GNNDYView All Competitors HKMPF Stock - Frequently Asked Questions Should I buy or sell Hikma Pharmaceuticals stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hikma Pharmaceuticals in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HKMPF shares. View HKMPF analyst ratings or view top-rated stocks. How have HKMPF shares performed in 2023? Hikma Pharmaceuticals' stock was trading at $18.87 at the beginning of 2023. Since then, HKMPF stock has increased by 9.4% and is now trading at $20.6401. View the best growth stocks for 2023 here. Is Hikma Pharmaceuticals a good dividend stock? Hikma Pharmaceuticals (OTCMKTS:HKMPF) pays an annual dividend of $0.74 per share and currently has a dividend yield of 3.59%. Read our dividend analysis for HKMPF. What is Hikma Pharmaceuticals' stock symbol? Hikma Pharmaceuticals trades on the OTCMKTS under the ticker symbol "HKMPF." How do I buy shares of Hikma Pharmaceuticals? Shares of HKMPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Hikma Pharmaceuticals' stock price today? One share of HKMPF stock can currently be purchased for approximately $20.64. How much money does Hikma Pharmaceuticals make? Hikma Pharmaceuticals (OTCMKTS:HKMPF) has a market capitalization of $4.55 billion and generates $2.52 billion in revenue each year. How many employees does Hikma Pharmaceuticals have? The company employs 8,700 workers across the globe. How can I contact Hikma Pharmaceuticals? Hikma Pharmaceuticals' mailing address is 1 NEW BURLINGTON PLACE, LONDON X0, W1S 2HR. The official website for the company is www.hikma.com. The company can be reached via phone at 442073992760, via email at investors@hikma.uk.com, or via fax at 44-20-7399-2761. This page (OTCMKTS:HKMPF) was last updated on 3/26/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.